Viridian Therapeutics, Inc. (LON:0K1R)
16.32
+0.23 (1.43%)
At close: Aug 11, 2025
Viridian Therapeutics Employees
Viridian Therapeutics had 143 employees as of December 31, 2024. The number of employees increased by 49 or 52.13% compared to the previous year.
Employees
143
Change (1Y)
49
Growth (1Y)
52.13%
Revenue / Employee
1.56K GBP
Profits / Employee
-1.41M GBP
Market Cap
1.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 143 | 49 | 52.13% |
Dec 31, 2023 | 94 | 8 | 9.30% |
Dec 31, 2022 | 86 | 36 | 72.00% |
Dec 31, 2021 | 50 | 23 | 85.19% |
Dec 31, 2020 | 27 | -19 | -41.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Oxford Nanopore Technologies | 1,382 |
HUTCHMED (China) | 1,811 |
Viridian Therapeutics News
- 7 days ago - Viridian (VRDN) Q2 Net Loss Widens 55% - The Motley Fool
- 7 days ago - Viridian Therapeutics GAAP EPS of -$1.00 beats by $0.03, revenue of $0.08M beats by $0.03M - Seeking Alpha
- 7 days ago - Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results - Business Wire
- 9 days ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments - Business Wire
- 5 weeks ago - Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Viridian Therapeutics: The Song Remains The Same - Seeking Alpha
- 2 months ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire